Published in Int Arch Med on November 05, 2010
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Sparse optical microstimulation in barrel cortex drives learned behaviour in freely moving mice. Nature (2008) 6.08
Electric field mediated gene transfer. Biochem Biophys Res Commun (1982) 3.91
In vivo mammalian brain imaging using one- and two-photon fluorescence microendoscopy. J Neurophysiol (2004) 3.28
Single-cell electroporation for gene transfer in vivo. Neuron (2001) 3.15
Targeted patch-clamp recordings and single-cell electroporation of unlabeled neurons in vivo. Nat Methods (2007) 2.98
'Shocking' developments in chick embryology: electroporation and in ovo gene expression. Nat Cell Biol (1999) 2.87
Microfluidic control of cell pairing and fusion. Nat Methods (2009) 2.58
In vivo simultaneous tracing and Ca(2+) imaging of local neuronal circuits. Neuron (2007) 2.23
Targeted electroporation in Xenopus tadpoles in vivo--from single cells to the entire brain. Differentiation (2002) 1.91
A versatile microporation technique for the transfection of cultured CNS neurons. J Neurosci Methods (1999) 1.80
NMDA receptors activated by subventricular zone astrocytic glutamate are critical for neuroblast survival prior to entering a synaptic network. Neuron (2010) 1.78
Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg (1999) 1.78
In vivo single-cell electroporation for transfer of DNA and macromolecules. Nat Protoc (2006) 1.66
Efficient in vivo electroporation of the postnatal rodent forebrain. PLoS One (2008) 1.59
Gene transfer into cultured mammalian embryos by electroporation. Methods (2001) 1.46
High-efficiency transfection of mammalian neurons via nucleofection. Nat Protoc (2007) 1.46
High-efficiency transfection of individual neurons using modified electrophysiology techniques. J Neurosci Methods (2003) 1.33
Calcium indicator loading of neurons using single-cell electroporation. Pflugers Arch (2007) 1.31
Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol (2001) 1.28
Electroporation for targeted gene transfer. Expert Opin Drug Deliv (2005) 1.27
Single-cell electroporation. Pflugers Arch (2001) 1.25
Transfer of monoclonal antibodies into mammalian cells by electroporation. J Biol Chem (1989) 1.25
Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents. J Neurosci (2003) 1.21
Gain- and loss-of-function in chick embryos by electroporation. Mech Dev (2004) 1.20
Targeted single-cell electroporation of mammalian neurons in vivo. Nat Protoc (2009) 1.16
Cationic liposomes for gene delivery. Expert Opin Drug Deliv (2005) 1.15
Activity dependence of cortical axon branch formation: a morphological and electrophysiological study using organotypic slice cultures. J Neurosci (2005) 1.11
Selective gene expression by postnatal electroporation during olfactory interneuron neurogenesis. PLoS One (2008) 1.10
Interplay between laminar specificity and activity-dependent mechanisms of thalamocortical axon branching. J Neurosci (2007) 1.10
Electrotransfer as a non viral method of gene delivery. Curr Gene Ther (2007) 1.10
Transferring genes into cultured mammalian embryos by electroporation. Dev Growth Differ (2008) 1.08
Application of electroporation in recombinant DNA technology. Methods Enzymol (1993) 1.06
Labeling neurons in vivo for morphological and functional studies. Curr Opin Neurobiol (2004) 1.02
Single cell electroporation in vivo within the intact developing brain. J Vis Exp (2008) 1.01
96-well electroporation method for transfection of mammalian central neurons. Biotechniques (2006) 0.97
Electroporation of primary neural cultures: a simple method for directed gene transfer in vitro. Histochem Cell Biol (2002) 0.95
Intranuclear microinjection of DNA into dissociated adult mammalian neurons. J Vis Exp (2009) 0.91
Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol (2008) 0.91
Transfection of cultured primary neurons via nucleofection. Curr Protoc Neurosci (2009) 0.89
Single-cell electroporation of adult sensory neurons for gene screening with RNA interference mechanism. J Neurosci Methods (2008) 0.85
Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures. J Neurosci Methods (2008) 0.85
Electroporation-mediated gene therapy. Expert Opin Drug Deliv (2007) 0.85
Heterologous expression of the invertebrate FMRFamide-gated sodium channel as a mechanism to selectively activate mammalian neurons. Neuroscience (2008) 0.83
Electroporation: an arsenal of application. Cytotechnology (2007) 0.82
Simultaneous imaging of morphological plasticity and calcium dynamics in dendrites. Nat Protoc (2006) 0.82
Single cell electroporation method for axon tracing in cultured slices. Dev Growth Differ (2008) 0.80
Electroporation of neurons and growth cones in Aplysia californica. J Neurosci Methods (2005) 0.80
In vivo targeting of subventricular zone astrocytes. Prog Neurobiol (2010) 0.79
Transfection of rat brain cells by electroporation. J Neurosci Methods (1997) 0.78
A practical device for pinpoint delivery of molecules into multiple neurons in culture. Brain Cell Biol (2008) 0.78
A method of combined single-cell electrophysiology and electroporation. J Neurosci Methods (2006) 0.76
Rational therapeutic approaches to progressive supranuclear palsy. Brain (2010) 1.11
Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neurochem (2011) 0.94
Dopaminergic reward system: a short integrative review. Int Arch Med (2010) 0.93
Mechanisms of sleep-wake cycle modulation. CNS Neurol Disord Drug Targets (2009) 0.90
Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol (2011) 0.89
Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets (2013) 0.88
Caffeine and suicide: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.88
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab. Ann Neurol (2015) 0.86
Relationship between early and late stages of information processing: an event-related potential study. Neurol Int (2012) 0.84
EEG-based brain-computer interfaces: an overview of basic concepts and clinical applications in neurorehabilitation. Rev Neurosci (2010) 0.84
Psychosocial stress but not exercise increases cortisol and reduces state anxiety levels in school classes - results from a stressor applicable in large group settings. CNS Neurol Disord Drug Targets (2014) 0.84
Functional coupling of sensorimotor and associative areas during a catching ball task: a qEEG coherence study. Int Arch Med (2012) 0.84
Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1. Neuropharmacology (2011) 0.84
Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health (2013) 0.83
Natural toxins implicated in the development of Parkinson's disease. Ther Adv Neurol Disord (2011) 0.83
A new dopaminergic nigro-olfactory projection. Acta Neuropathol (2015) 0.82
Adult neurogenesis in the hypothalamus: evidence, functions, and implications. CNS Neurol Disord Drug Targets (2011) 0.82
Depression as a comorbidity in Behcet's syndrome. CNS Neurol Disord Drug Targets (2014) 0.82
Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol Disord Drug Targets (2013) 0.81
Commentary: the effects of psychological stress on microglial cells in the brain. CNS Neurol Disord Drug Targets (2015) 0.81
Zonisamide: aspects in neuroprotection. Exp Neurol (2010) 0.81
Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiol Dis (2011) 0.81
Is mental practice an effective adjunct therapeutic strategy for upper limb motor restoration after stroke? A systematic review and meta- analysis. CNS Neurol Disord Drug Targets (2015) 0.81
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PLoS One (2011) 0.81
Origin of the dopaminergic innervation of adult neurogenic areas. J Comp Neurol (2014) 0.81
Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review. Psychiatr Danub (2016) 0.81
Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction. CNS Neurol Disord Drug Targets (2013) 0.80
Quantitative evaluation of the human subventricular zone. Brain (2012) 0.80
Time perception impairs sensory-motor integration in Parkinson's disease. Int Arch Med (2013) 0.80
Changes in alpha band activity associated with application of the compression of fourth ventricular (CV-4) osteopathic procedure: a qEEG pilot study. J Bodyw Mov Ther (2012) 0.80
Intermittent maximal exercise improves attentional performance only in physically active students. Arch Med Res (2012) 0.80
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS Neurol Disord Drug Targets (2014) 0.80
The value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: an integrative review. CNS Neurol Disord Drug Targets (2011) 0.79
Motor neuron disease and acquired axonal neuropathy association in HIV infection: case report and update. Curr HIV Res (2012) 0.79
Chest pain, panic disorder and coronary artery disease: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.79
Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders? Neuropharmacology (2011) 0.78
Partial motor status epilepticus as a clinical manifestation of carotid stenosis. Int Arch Med (2010) 0.78
Bupropion in the depression-related sexual dysfunction: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.78
Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease. Med Hypotheses (2011) 0.77
Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Social Anxiety Disorder: Case Reports and a Review of the Literature. Clin Pract Epidemiol Ment Health (2013) 0.77
Premotor and occipital theta asymmetries as discriminators of memory- and stimulus-guided tasks. Brain Res Bull (2011) 0.77
The mirror neuron system in post-stroke rehabilitation. Int Arch Med (2013) 0.77
Executive function impairments in patients with depression. CNS Neurol Disord Drug Targets (2014) 0.77
Repetitive transcranial magnetic stimulation to treat substance use disorders and compulsive behavior. CNS Neurol Disord Drug Targets (2015) 0.77
A software tool for the analysis of neuronal morphology data. Int Arch Med (2014) 0.77
The effects of bromazepam over the temporo-parietal areas during the performance of a visuomotor task: a qEEG study. Neurosci Lett (2011) 0.76
Clonazepam for the treatment of panic disorder. Curr Drug Targets (2013) 0.76
Locally induced neural stem cells/pluripotent stem cells for in vivo cell replacement therapy. Int Arch Med (2008) 0.76
Does immobilization of dependent hand promote adaptative changes in cerebral cortex? An analysis through qEEG asymmetry. Neurosci Lett (2012) 0.76
Oxidative Stress and Adult Neurogenesis. Stem Cell Rev (2015) 0.76
Current pharmacological interventions in panic disorder. CNS Neurol Disord Drug Targets (2014) 0.76
Sex therapy for female sexual dysfunction. Int Arch Med (2013) 0.76
rTMS to treat social anxiety disorder: a case report. Rev Bras Psiquiatr (2013) 0.76
Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. CNS Neurol Disord Drug Targets (2012) 0.76
Cortical reorganization after hand immobilization: the beta qEEG spectral coherence evidences. PLoS One (2013) 0.76
Effects of Aerobic Exercise on Anxiety Disorders: A Systematic Review. CNS Neurol Disord Drug Targets (2015) 0.76
Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington's disease-like rat model. Brain Stimul (2012) 0.76
From Mind to Body: Is Mental Practice Effective on Strength Gains? A Meta-Analysis. CNS Neurol Disord Drug Targets (2015) 0.76
Can Transcranial Direct Current Stimulation Improve the Resistance Strength and Decrease the Rating Perceived Scale in Recreational Weight-Training Experience? J Strength Cond Res (2016) 0.76
Neural Mechanisms of Exercise: Anti-Depression, Neurogenesis, and Serotonin Signaling. CNS Neurol Disord Drug Targets (2015) 0.75
Commentary: Adult-born neurons with unique GABAergic synapses. CNS Neurol Disord Drug Targets (2013) 0.75
Effects of Exercise on Physical and Mental Health, and Cognitive and Brain Functions in Schizophrenia: Clinical and Experimental Evidence. CNS Neurol Disord Drug Targets (2015) 0.75
Panic attack triggering myocardial ischemia documented by myocardial perfusion imaging study. A case report. Int Arch Med (2012) 0.75
Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. Int Arch Med (2011) 0.75
Utilizing neuro-inflammation: turning degeneration to regeneration. CNS Neurol Disord Drug Targets (2012) 0.75
Effects of Methylphenidate on performance of a practical pistol shooting task: a quantitative electroencephalography (qEEG) study. Int Arch Med (2011) 0.75
Evidence of nestin-positive cells in the human cutaneus Meissner and Pacinian corpuscles. CNS Neurol Disord Drug Targets (2012) 0.75
A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine. J Clin Psychopharmacol (2017) 0.75
Implications of movement-related cortical potential for understanding neural adaptations in muscle strength tasks. Int Arch Med (2014) 0.75
Neural stem cells and neurodegeneration. CNS Neurol Disord Drug Targets (2012) 0.75
Neural Mechanism of Exercise: Neurovascular Responses to Exercise. CNS Neurol Disord Drug Targets (2015) 0.75
Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review. CNS Neurol Disord Drug Targets (2015) 0.75
Neuroscience of Exercise: Association Among Neurobiological Mechanisms and Mental Health. CNS Neurol Disord Drug Targets (2015) 0.75
Repetitive transcranial magnetic stimulation (rTMS) to treat refractory panic disorder patient: a case report. CNS Neurol Disord Drug Targets (2014) 0.75
Activity-Dependent Neurorehabilitation Beyond Physical Trainings: "Mental Exercise" Through Mirror Neuron Activation. CNS Neurol Disord Drug Targets (2015) 0.75
Analysis of slow- and fast-α band asymmetry during performance of a saccadic eye movement task: dissociation between memory- and attention-driven systems. J Neurol Sci (2011) 0.75
Neural Mechanisms of Exercise: Effects on Gut Miccrobiota and Depression. CNS Neurol Disord Drug Targets (2015) 0.75
Aerobic Exercise Does Not Predict Brain Derived Neurotrophic Factor And Cortisol Alterations in Depressed Patients. CNS Neurol Disord Drug Targets (2015) 0.75
Colchicine as a promising drug for Parkinson's disease. Med Hypotheses (2010) 0.75
Changes of synaptic plasticity in multiple sclerosis. CNS Neurol Disord Drug Targets (2015) 0.75
Research highlights. The genetic basis of "running for longevity". CNS Neurol Disord Drug Targets (2012) 0.75
Clinical implication of Meissner`s corpuscles. CNS Neurol Disord Drug Targets (2012) 0.75
Nanomaterials for Neurology: State-of-the-Art. CNS Neurol Disord Drug Targets (2016) 0.75
Potential Therapeutic Effects of Physical Exercise for Bipolar Disorder. CNS Neurol Disord Drug Targets (2015) 0.75
Cognitive mechanisms and motor control during a saccadic eye movement task: evidence from quantitative electroencephalography. Arq Neuropsiquiatr (2012) 0.75
Hemispheric differences over frontal theta-band power discriminate between stimulus- versus memory-driven saccadic eye movement. Neurosci Lett (2011) 0.75
[Hypocretins, peptides associated with narcolepsy]. Gac Med Mex (2008) 0.75
Neurobiology of Bipolar Disorder: Abnormalities on Cognitive and Cortical Functioning and Biomarker Levels. CNS Neurol Disord Drug Targets (2016) 0.75
Neurological aspects of grief. CNS Neurol Disord Drug Targets (2014) 0.75
Characterization of Mitogen-Activated Protein Kinase Expression in Nucleus Accumbens and Hippocampus of Rats Subjected to Food Selection in the Cafeteria Diet Protocol. CNS Neurol Disord Drug Targets (2016) 0.75
The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment. CNS Neurol Disord Drug Targets (2009) 0.75